The clinical application of intra-aortic balloon pumping in treating serious coronary heart disease
10.3760/cma.j.issn.1008-6706.2010.23.016
- VernacularTitle:主动脉内球囊反搏在严重冠心病中的临床应用
- Author:
Guopei ZHANG
;
Yajun ZHANG
;
Jianxiang SONG
;
Qiyin ZHOU
- Publication Type:Journal Article
- Keywords:
Intra-aortic balloon pumping;
Therapeutics
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(23):3198-3199
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect of intra-aortic balloon pumping(IABP)in treating serious coronary heart disease. MethodsA retrospective analysis was performed on 19 patients who suffered from serious coronary heart disease and accepted IABP therapy,the differences of mean arterial pressure before and after treatment were compared.In order to compare the in-hospital mortality,the patients were divided into 2 groups:6 of 19 patients accepted single IABP therapy,13 of 19 patients attempted IABP and revascularization(thrombolytic/percutaneous coronary intervention/coronary artery bypass graft)therapy. ResultsBedside success rate of IABP operation was 100%without complication.Effective rate was 89.5%(17/19),2 patients who were irreversible phase of cardiogenic shock,were an ineffective treatment.The patient's mean arterial pressure increased from(52.1 ± 18.4)mm Hg to(78.3 20.8)mm Hg after using IA BP for 30 minutes(P＜0.01).The in-hospital mortality was significantly lower in patients received revascularization therapy in addition to IABP compared with patients who had IABP support alone 7.7% vs 83.3%(P＜0.01). ConclusionIABP in treating serious coronary heart disease was safe and effective.IABP treatment before irreversible phase of shock and revascularization therapy following IABP are the key to decrease in-hospital mortality.
